Eleonora Teplinsky

816 total citations
29 papers, 324 citations indexed

About

Eleonora Teplinsky is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Eleonora Teplinsky has authored 29 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Eleonora Teplinsky's work include HER2/EGFR in Cancer Research (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Eleonora Teplinsky is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Eleonora Teplinsky collaborates with scholars based in United States and Canada. Eleonora Teplinsky's co-authors include Franco M. Muggia, Thomas J. Herzog, Francisco J. Esteva, Komal Jhaveri, Kent Friedman, Lidia Schapira, Sarat Chandarlapaty, Melissa Alexander, Shanu Modi and Rui Wang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Eleonora Teplinsky

23 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eleonora Teplinsky United States 11 145 109 53 46 39 29 324
Sarah V. Colonna United States 12 178 1.2× 79 0.7× 50 0.9× 30 0.7× 38 1.0× 28 315
Davide Soldato Italy 10 192 1.3× 50 0.5× 56 1.1× 94 2.0× 32 0.8× 27 303
Jessé Lopes da Silva Brazil 7 184 1.3× 128 1.2× 91 1.7× 60 1.3× 48 1.2× 29 363
Maria Litwiniuk Poland 10 245 1.7× 117 1.1× 98 1.8× 74 1.6× 15 0.4× 52 442
Devin Worster United States 4 153 1.1× 255 2.3× 55 1.0× 50 1.1× 34 0.9× 6 410
J. Eglītis Latvia 12 246 1.7× 213 2.0× 115 2.2× 64 1.4× 29 0.7× 21 514
E.C. Faulkner United States 9 153 1.1× 121 1.1× 76 1.4× 77 1.7× 64 1.6× 20 500
Monika Sobočan Slovenia 13 62 0.4× 102 0.9× 86 1.6× 26 0.6× 29 0.7× 47 423
Daniel Boehm Germany 11 197 1.4× 149 1.4× 120 2.3× 57 1.2× 33 0.8× 25 540
Anita Zarina Bustam Malaysia 12 131 0.9× 85 0.8× 78 1.5× 65 1.4× 19 0.5× 26 355

Countries citing papers authored by Eleonora Teplinsky

Since Specialization
Citations

This map shows the geographic impact of Eleonora Teplinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Teplinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Teplinsky more than expected).

Fields of papers citing papers by Eleonora Teplinsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleonora Teplinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Teplinsky. The network helps show where Eleonora Teplinsky may publish in the future.

Co-authorship network of co-authors of Eleonora Teplinsky

This figure shows the co-authorship network connecting the top 25 collaborators of Eleonora Teplinsky. A scholar is included among the top collaborators of Eleonora Teplinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleonora Teplinsky. Eleonora Teplinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teplinsky, Eleonora, et al.. (2025). Collateral damage: rhabdomyolysis from concurrent abemaciclib and rosuvastatin use. Breast Cancer Research and Treatment. 215(1). 6–6.
2.
Bhardwaj, Prarthna V, et al.. (2024). Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship. Current Oncology Reports. 26(1). 34–45. 13 indexed citations
3.
Teplinsky, Eleonora, et al.. (2024). From diagnosis to survivorship addressing the sexuality of women during cancer. The Oncologist. 29(12). 1014–1023. 5 indexed citations
4.
5.
Teplinsky, Eleonora, et al.. (2024). Results of the COMPARE-GPT study: Comparison of medication package inserts and GPT-4 cancer drug information.. Journal of Clinical Oncology. 42(16_suppl). e13646–e13646. 1 indexed citations
6.
Teplinsky, Eleonora, et al.. (2024). Women’s insights on sexual health after breast cancer (WISH-BREAST).. Journal of Clinical Oncology. 42(16_suppl). 12132–12132. 1 indexed citations
7.
Teplinsky, Eleonora, et al.. (2023). Social Media as a Tool to Directly Address Misinformation in Health Care and Promote Patient Education. International Journal of Radiation Oncology*Biology*Physics. 117(2). e512–e512. 1 indexed citations
8.
Teplinsky, Eleonora, Emily K. Drake, Stacy Loeb, et al.. (2022). Online Medical Misinformation in Cancer: Distinguishing Fact From Fiction. JCO Oncology Practice. 18(8). 584–589. 31 indexed citations
9.
Teplinsky, Eleonora, et al.. (2020). Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer. Clinical Breast Cancer. 21(1). 1–9. 15 indexed citations
10.
Teplinsky, Eleonora & Franco M. Muggia. (2017). EGFR and HER2: is there a role in ovarian cancer?. Translational Cancer Research. 4(1). 107–117. 26 indexed citations
11.
Teplinsky, Eleonora, et al.. (2017). Integrating targeted drugs with taxanes and platinums: opportunities and challenges. Translational Cancer Research. 4(1). 127–136.
12.
Jhaveri, Komal, Rui Wang, Eleonora Teplinsky, et al.. (2017). A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer. Breast Cancer Research. 19(1). 89–89. 46 indexed citations
13.
Teplinsky, Eleonora & Thomas J. Herzog. (2017). The efficacy of trabectedin in treating ovarian cancer. Expert Opinion on Pharmacotherapy. 18(3). 313–323. 18 indexed citations
14.
Benedict, Catherine, Bridgette Thom, Eleonora Teplinsky, Jane Carleton, & Joanne Frankel Kelvin. (2016). Family-building After Breast Cancer: Considering the Effect on Adherence to Adjuvant Endocrine Therapy. Clinical Breast Cancer. 17(3). 165–170. 12 indexed citations
15.
Muggia, Franco M. & Eleonora Teplinsky. (2015). Introduction: moving beyond chemotherapy. Translational Cancer Research. 4(1). 1–2. 1 indexed citations
16.
Teplinsky, Eleonora & Francisco J. Esteva. (2015). Systemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here?. Current Oncology Reports. 17(10). 46–46. 6 indexed citations
17.
Jhaveri, Komal, Eleonora Teplinsky, Deborah Silvera, et al.. (2015). Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy. Clinical Breast Cancer. 16(2). 113–122.e1. 50 indexed citations
18.
Teplinsky, Eleonora & Franco M. Muggia. (2014). Targeting HER2 in ovarian and uterine cancers: Challenges and future directions. Gynecologic Oncology. 135(2). 364–370. 57 indexed citations
19.
Teplinsky, Eleonora, Ilan Weisberg, Martin Wolff, et al.. (2013). Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature. Breast Cancer Research and Treatment. 141(2). 167–172. 15 indexed citations
20.
Balk, Ethan M., et al.. (2007). Applicability of the Evidence Regarding Intensive Glycemic Control and Self-Monitored Blood Glucose to Medicare Patients with Type 2 Diabetes. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah V. Colonna Breakdown of academic impact, for papers by Davide Soldato Breakdown of academic impact, for papers by Jessé Lopes da Silva Breakdown of academic impact, for papers by Maria Litwiniuk Breakdown of academic impact, for papers by Devin Worster Breakdown of academic impact, for papers by J. Eglītis Breakdown of academic impact, for papers by E.C. Faulkner Breakdown of academic impact, for papers by Monika Sobočan Breakdown of academic impact, for papers by Daniel Boehm Breakdown of academic impact, for papers by Anita Zarina Bustam
Rankless by CCL
2026